Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03610971
Title Treatment Free Remission After Combination Therapy with Ruxolitinib Plus Tyrosine Kinase Inhibitors
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors H. Lee Moffitt Cancer Center and Research Institute
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
H. Lee Moffitt Cancer Center and Research Institute ACTIVE_NOT_RECRUITING Tampa Florida 33612 United States Details
Emory -Winship Cancer Institute RECRUITING Atlanta Georgia 30322 United States Details
Memorial Sloan Kettering - Bergen RECRUITING Montvale New Jersey 07645 United States Details
Roswell Park Comprehensive Cancer Center RECRUITING Buffalo New York 14263 United States Details
David H. Koch Center for Cancer Care at Memorial Sloan Kettering RECRUITING New York New York 10021 United States Details
Duke University Hospital RECRUITING Durham North Carolina 27710 United States Details
Oregon Health & Science University RECRUITING Portland Oregon 97239 United States Details
Fred Hutchinson Cancer Research Center WITHDRAWN Seattle Washington 98109 United States Details
Froedtert Hospital & the Medical College of Wisconsin ACTIVE_NOT_RECRUITING Milwaukee Wisconsin 53226 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field